Sight Sciences (SGHT) EPS (Basic) Growth (3y) (2023 - 2026)
Sight Sciences (SGHT) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 17.98% |
| 10 | Sight Sciences | 457.30 Mn | 377.55 Mn | 21.37 Mn | 35.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.50% |
| Mar 31, 2026 | 11.96% |
| Dec 31, 2025 | 39.10% |
| Sep 30, 2025 | 30.47% |
| Jun 30, 2025 | 22.75% |
| Mar 31, 2025 | 17.36% |
| Dec 31, 2024 | 26.54% |
| Sep 30, 2024 | 20.09% |
| Jun 30, 2024 | 48.73% |
| Mar 31, 2024 | 36.54% |
| Dec 31, 2023 | 39.10% |
| Sep 30, 2023 | 32.03% |
| Jun 30, 2023 | 29.82% |